MARK3
Top inhibitors
| Drug | Inhibition % | Gini |
|---|---|---|
| Midostaurin | 97.4 | 0.50 |
| Brigatinib | 90.3 | 0.51 |
| Defactinib | 80.5 | 0.45 |
| Baricitinib | 67.2 | 0.62 |
| Sunitinib | 66.0 | 0.52 |
| Upadacitinib | 60.1 | 0.66 |
| Repotrectinib | 59.5 | 0.61 |
| Axitinib | 52.9 | 0.69 |
| Bosutinib | 36.6 | 0.55 |
| Fedratinib | 36.4 | 0.58 |
| Pemigatinib | 35.5 | 0.72 |
| Rabusertib | 33.8 | 0.69 |
| Ruxolitinib | 31.3 | 0.59 |
| Crizotinib | 30.8 | 0.58 |
| Selpercatinib | 22.5 | 0.64 |
Known variants
No variants catalogued.